b"Sixty Years of Touchingwith four production lines that are optimized forand Cell Therapy Technologies, says the film Patients Lives efficient, automated, precision manufacturing.shows the struggle endured by a family when Today, it employs 530 people with three highlya member battled leukemia. While stem cell Terumo Blood and Cell Technologies (Terumoautomated manufacturing lines. treatments can save lives, not every patient BCT) doubled down on Colorado when itThe plant focuses on single-use sets for sourcehas access to revolutionary cell and gene topped off a 170,000-square-foot expansionplasma collections for Terumo BCTs new Rikatherapies. to its Douglas County operations in 2022. Plasma Donation System, which was clearedTerumoBCTisnowexploringwaysto The $250 million state-of-the-art manufacturingby the U.S. Food & Drug Administrationprovidemorepatientsaccesstosuch facility deepens the companys footprint and(FDA). The automated technology aims totechnologiesandtrainingproviderson financial commitment to the state, where itimprove the efficiency and quality of plasmaturning to therapeutic apheresis as first-line employs 2,000 people out of its 8,000-persondonation, while maintaining safety and plasmatreatment of a variety of diseases. Apheresis global workforce. The $1.5 billion division ofsupplyall with donors and plasma centeris the nonsurgical procedure of removing Japanese-based conglomerate Terumo Corp.employees in mind. The companys missionabnormal cells or substances from the blood boasts a 60-year track record of success inis to contribute to society through healthcareto treat diseases. One promising treatment Colorado. Its technology can collect, process,and serve more patients.is filtering for amyloid beta plaque, which is and separate blood and cells, filter donorIn 2023, Terumo BCT also appeared in thewhat causes Alzheimers. A 10-year clinical plasma and other products for manufacturingConnecting the Dots series, a BBC seriesstudy by healthcare company Grifols wrapped cell and gene therapies.highlighting heroes that are revolutionizingup recently, showing the promise of that We continue to offer quality jobs whilehealthcare. Terumo BCTs story shows how itstechnology on the disease.making products that touch patients livesSpectra Optia Apheresis System plays a criticalBlood is an essential medicine, dHaenens everysecondofeveryday,saysChrisrole in emerging cell therapies and facilitatingsays. Our healthy blood and cells have the Williams, Terumo BCTs Senior Vice Presidenttreatments to help people struggling with ademonstrated power to bring healing. of Global Manufacturing.variety of diseases such as leukemia.At full capacity, the Douglas County operationVeerledHaenens,GeneralManagerof will employ 300 people and eventually run 24/7Terumo BCTs Global Therapeutic Systems We continue to offer quality jobs while making products that touch patients' lives every second of every day.CHRIS WILLIAMSSENIOR VICE PRESIDENT, GLOBAL MANUFACTURINGTERUMO BLOOD AND CELL TECHNOLOGIESLeft: Amanda Stone works on Spectra Optia Apheresis System at Terumo BCTs Lakewood campus. The device is used for 94% of white blood cell collections in the U.S. and 67% worldwide. Above: Myint Zaw works on building a Spectra Optia Apheresis System pump panel. It's used in procedures such as stem cell collections, therapeutic plasma exchange, and other cell processing.12 BIOSCIENCE COLORADO 2024-2025"